Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT06364163

Effect of Herring Oil Concentrate on LDL Cholesterol Concentration in Adults

High cholesterol concentration is a major risk factor for cardiovascular disease (CVD), and consumption of fish has been associated with a lower CVD risk in several studies. The beneficial health effects of consuming fish have traditionally been ascribed to the long-chain PUFA (LC-PUFA) EPA (C20:5n-3) and DHA (C22:6n-3), although consumption of fish oils or concentrates with high EPA and DHA contents does not affect the cholesterol concentration in humans and lowers the cholesterol concentration in rats and mice only when given in very high doses. Fish oils contain a plethora of fatty acids besides EPA and DHA, and in recent years, increased focus has been on the long-chain MUFA (LC-MUFA) cetoleic acid (C22:1n-11). Cetoleic acid is found in high amounts in oils from certain fish species such as herring, which has relatively low contents of both EPA and DHA. The investigators have recently summarised and meta-analysed the available literature that investigates the effects of diets containing fish oils or fish oil concentrates that have a high content of cetoleic acid but low or no content of EPA and DHA on cholesterol concentration in rodents, showing that cetoleic acid-rich fish oils and concentrates prevent high cholesterol concentration.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Age range

20 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Bergen

Bergen, Norway

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • BMI over 25 kg/m2
  • Stable body weight last 3 months

Exclusion criteria

  • Allergies towards fish, milk, egg, gluten
  • Tobacco use (cigarettes or snus)
  • Diseases affecting the heart, intestinal function, kidney function or insulin secretion
  • Use of medications targeting cholesterol -or glucose metabolism
  • Use of dietary supplements
  • Pregnant or breastfeeding
  • Following a strict diet
  • Had bariatric surgery or using medications for weight loss
  • Recent or planned surgical procedures
  • High intake of fish/seafood

Treatment and study plan

Herring oil concentrate

Dietary Supplement

Capsules containing herring oil concentrate, taken daily for 8 weeks.

Control

Dietary Supplement

Capsules containing control oil, taken daily for 8 weeks.

Primary outcomes

  1. Serum concentration of LDL-cholesterol

    Time frame: 8 weeks

    LDL-cholesterol will be measured in fasting serum samples

Secondary outcomes

  1. Serum concentration of HDL-cholesterol

    Time frame: 8 weeks

    HDL-cholesterol will be measured in fasting serum samples

  2. Serum concentration of total cholesterol

    Time frame: 8 weeks

    Total cholesterol will be measured in fasting serum samples

  3. Serum concentrations of apolipoproteins

    Time frame: 8 weeks

    Lipoproteins will be measured in fasting serum samples

  4. Serum concentrations of amino acids metabolites

    Time frame: 8 weeks

    Metabolites of amino acids will be measured in fasting serum samples

  5. Serum concentration of one-carbon pathway metabolites

    Time frame: 8 weeks

    Metabolites in the one-carbon pathway will be measured in fasting serum samples

  6. Fatty acid composition in leukocytes

    Time frame: 8 weeks

    Leukocytes will be isolated from fasting serum before quantification of fatty acids

  7. Serum concentration of glucose

    Time frame: 8 weeks

    Glucose will be measured in serum sampled in fasting condition

  8. Serum concentration of insulin

    Time frame: 8 weeks

    Insulin will be measured in serum sampled in fasting condition

  9. Body composition

    Time frame: 8 weeks

    Percent body fat will be measured using bioimpedance

Sponsors and collaborators

Lead sponsor

University of Bergen

Other

Collaborators

  • The Norwegian Seafood Research Fund

Registry information

Official study title

A Study on the Effect of Consuming a Herring Oil Concentrate on LDL Cholesterol Concentration in Adults With Overweight or Obesity

Important dates

Study start
2024
Primary completion
2026
Study completion
2027
First posted
Apr 15, 2024
Registry last updated
Oct 2, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.